Merit Medical Systems (NASDAQ:MMSI – Free Report) had its price objective raised by Raymond James from $105.00 to $110.00 in a research note published on Tuesday,Benzinga reports. Raymond James ...

Liquid biopsies are revolutionizing cancer diagnostics by offering distinct advantages over traditional incisional biopsy methods ... liquid biopsies are set to become a cornerstone of modern medicine ...

"I've been wanting to direct my own movie": Julia Stiles on making her directorial debut with 'Wish You Were Here' ...

NEWARK, Del, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The global biopsy device market is on track for steady growth over the next decade, with a projected valuation of USD 2,274.1 million in 2024 ...

Researchers have been able to identify at least three distinct subtypes of a rare type of bone cancer for the first ... due to the rarity of cases, limited biopsy material and the extensive ...

As healthcare systems worldwide continue to prioritize early diagnostics, the demand for biopsy devices is set to rise, with the market anticipated to grow 1.4 times its current size over the next ten ...

Stock analysts at Barrington Research increased their FY2026 earnings per share (EPS) estimates for shares of Merit Medical ...

Two million bone transplants are performed worldwide yearly, including half a million in the United States alone. Yet, a ...

Dec. 4, 2024 — A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted ... Scientists Develop ...

Lindsay R et al. (2006) A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of ...